Benign Concentric Annular Macular Dystrophy

Watchlist
Retrieved
2021-01-23
Source
Trials
Drugs

Benign concentric annular macular dystrophy (BCAMD) is a progressive autosomal dominant macular dystrophy characterized by parafoveal hypopigmentation followed by a retinitis pigmentosa-like phenotype (nyctalopia and peripheral vision loss) with a bull’s eye configuration.